Q4 2022 Holdings
Filed 2023-02-14 | 21 holdings | $372.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cincor Pharma Inc | COM | 17240Y109 | $60.7M | 4,937,646 | 16.3% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $59.6M | 4,408,379 | 16.0% |
| VOR Biopharma Inc | COM | 929033108 | $42.3M | 6,361,723 | 11.4% |
| Rallybio Corp | COM | 75120L100 | $24.5M | 3,730,724 | 6.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $21.7M | 1,196,298 | 5.8% |
| Pear Therapeutics Inc | CLASS A COM | 704723105 | $19.8M | 16,744,113 | 5.3% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $19.6M | 2,734,852 | 5.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $15.8M | 862,286 | 4.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $14.8M | 665,555 | 4.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $11.7M | 588,442 | 3.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $11.1M | 357,733 | 3.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $10.9M | 320,000 | 2.9% |
| Impel Neuropharma Inc | COM | 45258K109 | $10.8M | 2,884,791 | 2.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.1M | 790,440 | 2.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $8.8M | 300,000 | 2.4% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $8.2M | 384,626 | 2.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $6.6M | 587,600 | 1.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $5.9M | 446,266 | 1.6% |
| Homology Medicines Inc | COM | 438083107 | $5.7M | 4,535,919 | 1.5% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $3.6M | 225,583 | 1.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $858.0K | 1,134,511 | 0.2% |